Hospitals seeing more patients with uncontrolled blood pressure
“We need more research to understand why this is happening and how clinicians can help patients stay out of the hospital," one researcher said.
View Article'This is very exciting': New data on the link between diabetes and high blood...
An international research team thinks they've uncovered why so many hypertension patients also have diabetes.
View ArticleChinese herbal formula treats mild hypertension as well as prescription drug
Songling Xuemaikang capsules compare favorably with losartan, potentially providing specialists with a new treatment option.
View ArticleToo much Tylenol? Daily acetaminophen use may be bad for hypertension patients
Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.
View ArticleUnreliable? 76% of world’s blood pressure monitors have not been validated
Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy.
View Article4 new medications and technologies that could transform cardiology in 2022
The FDA has already approved one of the medications, with a decision on another expected by the end of April.
View ArticleHypertension patients benefit from new intervention focused on education,...
Improving the way we communicate with ED patients about their blood pressure could make a significant long-term impact on their health.
View ArticleFDA announces recall of hypertension medications due to potential cancer risk
The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication.
View ArticleRenal denervation linked to significant blood pressure reductions after 3 years
An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet.
View ArticleLinks to the ACC.22 late-breaking clinical trials
Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C.
View ArticleArterial stiffness may predict type 2 diabetes risk better than high blood...
Researchers tracked data from more than 11,000 adult patients, sharing their findings in Hypertension.
View ArticleRenal denervation improves blood pressure control, lowers risk of adverse...
Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.
View ArticleHow cocaine use affects outcomes for hospitalized heart failure patients
When cocaine users are hospitalized for heart failure, what should physicians expect? Are beta-blockers an effective treatment strategy?
View ArticleRAAS inhibitors lower risk of aneurysm rupture among patients with high blood...
Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.
View ArticleHigh blood pressure more than doubles risk of COVID-19 hospitalization
Adults that received three doses of an mRNA COVID vaccine were 2.6 times as likely to be hospitalized if they also had high blood pressure.
View ArticleCardiologists sound the alarm as ‘staggering’ new data suggest CVD rates in...
New data from the CDC and U.S. Census Bureau show just how bad CVD rates could get in the next few decades. Specialists agree that a lot of work is needed to help keep these estimates from becoming a...
View ArticleRenal denervation lowered blood pressure in two late-breaking TCT trials
Results from the Medtronic SYMPLICITY HTN-3 trial long-term results and the pivotal RADIANCE II trial for the Recor ultrasound renal denervation system lowered blood pressure effectively in...
View ArticlePulmonary artery denervation shows promise to treat pulmonary arterial...
Pulmonary artery denervation may offer a new therapy option for this difficult-to-treat population.
View ArticleFDA announces recall of 2 cardiovascular medications due to labeling mix-up
Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA.
View ArticleFDA announces new recall of blood pressure medication due to potential cancer...
Patients impacted by this recall are advised to speak with a physician about how to proceed.
View ArticleHow the COVID-19 pandemic has impacted blood pressure management in the US
A new analysis of more than 137,000 patients found that the early months of the pandemic were associated with some concerning trends for hypertension patients.
View ArticleVIDEO: SYMPLICITY HTN-3 and the future of renal denervation
Deepak Bhatt, MD, MPH, details long-term outcomes from the SYMPLICITY HTN-3 trial, which show a lasting impact on patients with uncontrolled hypertension.
View ArticleVIDEO: Key takeaways from AHA 2022
Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.
View ArticleHigher copayments lowered adherence for pulmonary artery hypertension...
The more a patient has to pay for medications, the less likely they are to take them. This was the finding of a new study showing how copayments may be a barrier to drugs to treat pulmonary arterial...
View ArticleSPYRAL HTN-ON MED renal denervation study did not meet primary endpoint
The SPYRAL HTN-ON MED renal denervation trial failed to show that renal denervation was superior to sham control at improving ambulatory blood pressure (ABPM), but that might have been due to patient...
View ArticleFormer surgeon general says cardiologists need to address hypertension and...
Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.
View ArticleTop 15 heart-healthy diets: DASH, Mediterranean come out on top
The list represents a collaboration between more than 30 nutritionists, doctors and epidemiologists.
View Article‘Revolutionary’ new CT scans identify the most common cause of high blood...
Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.
View ArticleWhere renal denervation stands for the treatment of drug-resistant hypertension
Ajay Kirtane, MD, director of the cardiac catheterization laboratories at NewYork-Presbyterian/Columbia University Irving Medical Center, explained the most recent clinical trial data on this topic.
View ArticleAHA President Michelle Albert on addressing health equity issues in cardiology
American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.
View ArticleHow cardiologists can address health disparities in their communities
Incoming 2023-2024 American College of Cardiology president Hadley Wilson, MD, shared insights on how to create health equity through grassroots community outreach programs.
View ArticleLarge study finds high rates of nonadherence to statin recommendations; women...
Many patients who would clearly benefit by lowered LDL cholesterol levels are choosing to forgo first-time recommendations for statin regimens, according to a population-level study.
View ArticleFDA panel to review renal denervation system PMA submissions
The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.
View ArticleCardiologists applaud WHO’s endorsement of polypills for CVD prevention
Valentin Fuster, MD, PhD, one of the world’s most prominent cardiologists, said "it is now our responsibility to ensure these treatments are widely available and used by the medical community.”
View ArticleFDA panel votes in favor of Recor Medical renal denervation system
A few members of the panel did question the device's efficacy and long-term durability. The FDA will now use these findings to make its final decision related to the system's approval.
View ArticleFDA panel votes not to endorse Medtronic renal denervation system
The vote was close, initially ending with a tie, but the panel ultimately decided there were too many questions related to the device's long-term benefits for patients with uncontrolled hypertension.
View ArticleLow-cost generic programs offer CVD medications at affordable prices—but...
Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe...
View ArticleFDA grants speedy review to Merck's new drug for pulmonary arterial hypertension
The FDA is expected to base its decision in part on the STELLAR clinical trial, which included 163 adult patients treated with subcutaneous sotatercept and 160 patients treated with a placebo.
View ArticleNo, a popular blood pressure medication does not increase heart failure risk,...
Dihydropyridines such as amlodipine have been the topic of some debate in recent months due to fears they lead to significant side effects.
View ArticleHeart-healthy diets may help women limit signs of cognitive decline later in...
More than 5,000 women were interviewed about their eating habits from 1985 to 1991, and then researchers followed up with them 30 years later. The full study was published in Alzheimer’s and Dementia.
View ArticleChatGPT tackles hypertension: Popular AI model a helpful resource for...
The study's authors communicated with ChatGPT-4 in both English and Japanese, noting that it appeared to struggle more with the complexities of the Japanese language.
View ArticleFDA approves first renal denervation system for uncontrolled hypertension
The system, designed for patients with uncontrolled hypertension who are unresponsive to medication, uses ultrasound ablation to target nerves in the renal arteries, increasing blood flow. This...
View ArticleFDA approves another renal denervation system for hypertension
This is the second time in a matter of weeks the FDA has approved an RDN system for uncontrolled hypertension. The SCAI issued a statement about this trend, calling it a “game-changer for both...
View ArticleADHD medications associated with heightened CVD risk
"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained.
View ArticleFirst US patient treated with Medtronic’s FDA-approved renal denervation system
Interventional cardiologist David Kandzari, MD, performed the procedure just days after the device received full FDA approval.
View ArticleSalt substitutes reduce hypertension risk by up to 40%
Many patients do not want to limit their salt intake, even when a doctor tells them the numerous health benefits. Salt substitutes may represent another way forward.
View ArticleFlexitarian diet, a plant-based option that includes small amounts of meat,...
The study, designed to compare flexitarians with vegans and omnivores, focused on young and middle-aged adults in good health who had been following the same diet for at least one full year.
View ArticleWorld’s first patient treated with new implantable device for pulmonary...
The procedure, performed on Feb. 14, was part of an early feasibility trial developed with help from the FDA.
View ArticleFDA approves new hypertension drug months after Idorsia reacquired rights for...
Aprocitentan, sold under the brand name Tryvio, is approved for patients with high blood pressure who are already taking other antihypertensive drugs.
View ArticleFDA approves new drugs for pulmonary arterial hypertension from Johnson &...
Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.
View Article
